Titan Pharmaceuticals (TTNP) SEC Filings & 10K Form $4.58 +0.02 (+0.44%) As of 09:53 AM Eastern Add Compare Share Share SEC Filings Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock Recent Titan Pharmaceuticals SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView06/03/20254:25 PMTitan Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 06/03/20254:25 PMTitan Pharmaceuticals (Subject)Form 42506/02/20254:20 PMTitan Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/05/202512:50 PMLoh Gabriel (Reporting)Titan Pharmaceuticals (Issuer)Form 3Initial statement of beneficial ownership of securities 05/02/20253:05 PMTitan Pharmaceuticals (Filer)Form DEF 14A04/22/20253:45 PMTitan Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 04/22/20253:30 PMTitan Pharmaceuticals (Filer)Form PRE 14A04/16/20252:49 PMJye Chay Weei (Reporting)Titan Pharmaceuticals (Issuer)Form 3Initial statement of beneficial ownership of securities 03/20/20253:30 PMTitan Pharmaceuticals (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 01/08/20253:05 PMTitan Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/08/20243:10 PMTitan Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/24/20248:16 AMTitan Pharmaceuticals (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/21/20247:32 AMSire Group Ltd. (Filed by)Titan Pharmaceuticals (Subject)Form SC 13D/A08/15/20248:29 AMTitan Pharmaceuticals (Filer)Form NT 10-Q08/15/20248:29 AMTitan Pharmaceuticals (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies AlloVir 10Q Form ProMIS Neurosciences 10Q Form Rallybio 10Q Form Cellectar Biosciences 10Q Form Bullfrog AI 10Q Form Gelteq 10Q Form Hoth Therapeutics 10Q Form NKGen Biotech 10Q Form iBio 10Q Form Abpro 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:TTNP) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
